Literature DB >> 6286714

Isopycnic separation of Escherichia coli cultures possessing colonization factor antigen I.

F R Giesa, I Zajac, H F Bartus, P Actor.   

Abstract

A culture of Escherichia coli possessing colonization factor antigen I was subjected to isopycnic separation on Percoll gradients. The results demonstrated successful division of the culture into two populations: (i) bacteria which cause mannose-resistant hemagglutination and (ii) bacteria which lack the ability to hemagglutinate in the presence of mannose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286714      PMCID: PMC272256          DOI: 10.1128/jcm.15.6.1074-1076.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  A rapid single centrifugation step method for the separation of erythrocytes, granulocytes and mononuclear cells on continuous density gradients of Percoll.

Authors:  A W Segal; A Fortunato; T Herd
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

3.  Rapid separation of rat peritoneal mast cells with Percoll.

Authors:  A Németh; P Röhlich
Journal:  Eur J Cell Biol       Date:  1980-02       Impact factor: 4.492

4.  Three characteristics associated with enterotoxigenic Escherichia coli isolated from man.

Authors:  D J Evans; D G Evans
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

5.  Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose.

Authors:  D J Evans; D G Evans; H L DuPont
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

6.  Synchronization of cell division in microorganisms by percoll gradients.

Authors:  R D Dwek; L H Kobrin; N Grossman; E Z Ron
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

7.  Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea.

Authors:  D G Evans; D J Evans; W S Tjoa; H L DuPont
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor.

Authors:  D G Evans; D J Evans; W Tjoa
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

9.  Enterotoxigenic Escherichia coli and other gram-negative bacteria of infantile diarrhea: surface antigens, hemagglutinins, colonization factor antigen, and loss of enterotoxigenicity.

Authors:  E Bäck; R Möllby; B Kaijser; G Stintzing; T Wadström; D Habte
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

10.  Analysis of parameters affecting the hemagglutination activity of Escherichia coli possessing colonization factor antigens: improved medium for observing erythrocyte agglutination.

Authors:  D M Sedlock; H F Bartus; I Zajac; P Actor
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

View more
  3 in total

1.  Pilus-mediated adherence of Haemophilus influenzae to human respiratory mucins.

Authors:  M Kubiet; R Ramphal; A Weber; A Smith
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Indications that the erythrocyte receptor involved in enterotoxigenic Escherichia coli attachment is a sialoglycoconjugate.

Authors:  H Bartus; P Actor; E Snipes; D Sedlock; I Zajac
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

3.  Characterization of Haemophilus influenzae type b fimbriae.

Authors:  T L Stull; P M Mendelman; J E Haas; M A Schoenborn; K D Mack; A L Smith
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.